🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareGLP-1 discontinuation: weight regain trajectory and mitigation strategies Page 4

GLP-1 discontinuation: weight regain trajectory and mitigation strategies

Dr.ObesityMed Thu, Apr 23, 2026 at 9:31 PM 16 replies 674 viewsPage 4 of 4
Dr.LipidDallas
VIP Member
2,678
14,567
Dec 2023
Dallas, TX
Apr 28, 2026 at 11:07 AM#16
Dr.EndoIndy said:
Maintenance phase reality on maintenance dosing: reached my goal 8 months ago and now I'm in maintenance.

Second this.

9 7pam_stl, wei_SG, cory_ATX and 6 others
Reply Quote Save Share Report
JenMemphis
Member
267
1,234
Jan 2025
Memphis, TN
Apr 28, 2026 at 2:36 PM#17
HPLC_Greg said:
The concept of "metabolic set point" and its relevance to maintenance dosing: the body actively defends a weight set point through hormonal feedback…

Epigenetic implications of GLP-1 therapy and maintenance dosing: emerging evidence suggests that sustained weight loss and metabolic improvement may produce epigenetic changes (DNA methylation, histone modification) that persist beyond drug discontinuation[1].

This is speculative but fascinating: could long-term GLP-1 agonist treatment "reprogram" metabolic gene expression? If so, it would explain why some patients maintain weight loss better than others after discontinuation.

More research needed, but the concept of pharmacologically-induced epigenetic remodeling is intellectually exciting.

References:
[1] Ling C, et al. Diabetologia. 2023;66(6):1078-1093.
10 8BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 7 others
Reply Quote Save Share Report
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Apr 28, 2026 at 6:05 PM#18
HPLC_Greg said:
The concept of "metabolic set point" and its relevance to maintenance dosing: the body actively defends a weight set point through hormonal feedback…

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

11 9kevin_tulsa, Dr.PainCLE, mike_mealprep and 8 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Apr 28, 2026 at 9:34 PM#19
HPLC_Greg said:
The concept of "metabolic set point" and its relevance to maintenance dosing: the body actively defends a weight set point through hormonal feedback…

Bookmarking. The distinction being drawn above is the one nobody else makes. Adding it to my notes with a link back to this thread.

Last edited: Apr 29, 2026 at 12:34 AM
12 10TirzTom, TrialTracker_MD, JennaRN and 9 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Apr 29, 2026 at 1:03 AM#20

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.

Last edited: Apr 29, 2026 at 5:03 AM
34 7PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 31 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register